Achieve Life Sciences (ACHV) Reports In-Line Q2 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q2 EPS of ($0.37), in-line with the analyst estimate of ($0.37).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
• Private Bancorp of America, Inc. (PBAM) Tops Q2 EPS by 26c
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue